Leukotrienes in Nociceptive Pathway and Neuropathic/Inflammatory Pain

• Published in: Biological & Pharmaceutical Bulletin Vol. 34; no. 8; pp. 1163 - 1169
• Main Authors: Noguchi, Koichi, Okubo, Masamichi
• Format: Journal Article
• Language: English; Japanese
• Published: Japan The Pharmaceutical Society of Japan 2011; Pharmaceutical Society of Japan; Japan Science and Technology Agency
• Subjects: Animals; dorsal root ganglion neuron; Ganglia, Spinal - metabolism; Hyperalgesia - etiology; Hyperalgesia - metabolism; Inflammation - complications; Inflammation - metabolism; Inflammation Mediators - metabolism; inflammatory pain; leukotriene; Leukotrienes - metabolism; microglia; Neuralgia - etiology; Neuralgia - metabolism; neuropathic pain; p38 Mitogen-Activated Protein Kinases - metabolism; Peripheral Nervous System - injuries; Peripheral Nervous System - metabolism; Peripheral Nervous System Diseases - etiology; Peripheral Nervous System Diseases - metabolism; Receptors, Leukotriene - metabolism; RNA, Messenger - metabolism; spinal cord; Spinal Cord - cytology; Spinal Cord - metabolism
• ISSN: 0918-6158; 1347-5215
• DOI: 10.1248/bpb.34.1163

The purpose of this review is to summarize the recent studies examining the expression of leukotrienes (LTs) and their receptors in nociceptive pathways, and their crucial roles in pathological pain conditions. LTs belong to a large family of lipid mediators, termed eicosanoids, which are derived from arachidonic acids and released from the cell membrane by phospholipases. LTs are known to be important factors in a variety of local and systemic diseases and allergic/inflammatory diseases. We examined whether LTs were implicated in neuropathic pain following peripheral nerve injury. Using the SNI model in rats, we investigated the expression of LT synthases and receptors mRNAs in the spinal cord and the roles on the pain behaviors. We found the expression of 5-lipoxygenase (5-LO), FLAP and the cysteinyl leukotrienes (CysLT1) mRNAs in spinal microglia, LTA4h and LTC4s mRNAs in both spinal neurons and microglia, and BLT1 mRNA in spinal neurons. Administration of the 5-LO inhibitor or the receptor antagonists suppressed mechanical allodynia. Our findings suggest that the increase of LT synthesis in spinal microglia produced via p38 mitogen-activated protein kinase (MAPK) plays a role in the generation of neuropathic pain. We also examined the expression and roles on pain behaviors of LT receptors in the dorsal root ganglion (DRG) using a peripheral inflammation model. The data indicate CysLT2 expressed in DRG neurons may play a role as a modulator of P2X3, and contribute to the potentiation of the neuronal activity following peripheral inflammation. This review summarizes the hypothesis that LTs might work in the spinal cord and primary afferent in pathological pain conditions.